跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,272 条关于
“GDUFA III”
全部
22,272
临床试验
16,899
药物
528
机构
43
资讯
4,802
上个月
FDA Unveils FY 2027 User Fee Rates: PDUFA Revenue Target Rises 6%, MDUFA Jumps 14%
去年
FDA Issues New Guidance on Controlled Correspondence for Generic Drug Development
去年
FDA Sets 2026 User Fee Rates for Generic and Animal Drug Programs with Inflation Adjustments
前天
FDA Reclassifies NRx Pharmaceuticals' ANDA Amendment for Preservative-Free Ketamine as Minor, Setting GDUFA Goal Date of November 10, 2026
去年
FDA Rehires Key Pharma User Fee Negotiators After Mass Layoffs Threaten Drug Review Process
去年
FDA Uncovers Significant Data Integrity Issues at Indian Contract Research Organization
11个月前
DYNAMIC-III Trial Shows Promise for ctDNA-Guided Chemotherapy De-escalation in Stage III Colon Cancer
去年
Lundbeck Launches Phase III Trial for Rare Neurological Disorder Treatment
去年
Anavex's Blarcamesine Shows Efficacy in Phase IIb/III Alzheimer's Trial
去年
EMA Approves Moleculin's Phase IIb/III Trial Application for AML Treatment
第 1 页,共 481 页
上一页
下一页